Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pediatrix Medical Group (PDX) -- Ignore unavailable to you. Want to Upgrade?

To: Bruce A. Brotnov who wrote (425)	1/24/2000 3:10:00 PM
From: William G. Foley	Read Replies (2) \| Respond to of 431

Company Press Release: Judge Grants Pediatrix's Motion to Dismiss Shareholder Litigation FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--January 21, 2000-- Pediatrix Medical Group, Inc., (NYSE: PDX - news), today announced that the U.S. District Court for the Southern District of Florida, has dismissed the class action complaint filed against it and several of its officers last year. The complaint had alleged federal securities law violations in connection with the company's billing practices. The court's opinion permits the plaintiffs to attempt to cure the deficiencies that the court found in their pleadings by filing a further amendment to their complaint by no later than February 3, 2000. If the plaintiffs fail to do so the dismissal will become final, subject only to any appeal the plaintiffs may take. Pediatrix was founded in 1979 and its physicians provide services at more than 145 neonatal intensive care units. Combined, Pediatrix and its subsidiaries employ more than 425 physicians in 25 states and Puerto Rico. Additional information is available on the Internet: pediatrix.com. Except for historical information, this press release contains certain forward-looking statements that involve risk and uncertainties that may cause actual results to differ materially from the statements made. Such factors include, but are not limited to, changing market conditions, the ability to successfully identify suitable acquisition candidates and to complete those acquisitions on favorable terms and other risks detailed from time to time by the Company in its filings with the U.S. Securities and Exchange Commission.